Adrenal Androgen Excess and Body Mass Index in Polycystic Ovary Syndrome

被引:45
|
作者
Moran, Carlos [1 ]
Arriaga, Monica [2 ]
Arechavaleta-Velasco, Fabian [1 ]
Moran, Segundo [3 ]
机构
[1] Mexican Inst Social Secur, Hlth Res Council, Res Unit Reprod Med, Mexico City, DF, Mexico
[2] Mexican Inst Social Secur, Med Unit High Specialty, Gynecol & Obstet Hosp Luis Castelazo Ayala 4, Mexico City, DF, Mexico
[3] Mexican Inst Social Secur, Hlth Res Council, Res Unit Clin Epidemiol, Mexico City, DF, Mexico
来源
关键词
INSULIN-RESISTANCE; DEHYDROEPIANDROSTERONE-SULFATE; WOMEN; PREVALENCE; OBESITY; SECRETION; ENDOCRINE; HYPERANDROGENISM; HYPERINSULINEMIA; HORMONE;
D O I
10.1210/jc.2014-2569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Adrenal hyperandrogenism affects approximately 25% of polycystic ovary syndrome (PCOS) patients but its relation to obesity is not totally understood. Objective: This study aimed to assess dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) levels in relation to body mass index (BMI) in PCOS. Design and Setting: This was a prospective observational study at an institutional practice at an obstetrics/gynecology hospital. Participants: The study included 136 PCOS patients, 20-35 years old, and 42 age-matched control women. The participants were classified with the BMI cutoff value of 27 kg/m(2) as follows: 1) high-BMI PCOS patients; 2) low-BMI PCOS patients; 3) high-BMI control women; and 4) low-BMI control women. The data were reanalyzed with the BMI cutoff value of 30 kg/m(2) to corroborate the findings in obese and nonobese patients. Main Outcome Measure(s): Blood samples were taken and LH, FSH, insulin, T, androstenedione (A4), DHEA, DHEAS, and glucose levels were determined. Homeostatic model assessment was calculated. Pelvic and abdominal ultrasound for ovarian morphology and adipose tissue, respectively, were performed. Results: Obese PCOS patients presented significantly more insulin resistance than nonobese PCOS patients. The LH levels and LH/FSH ratio were significantly higher in low-BMI than in high-BMI PCOS patients. The A4 and DHEAS levels were significantly higher in nonobese than in obese PCOS patients. Asignificant correlation between LH and A4 in nonobese PCOS patients was observed. The frequency of hyperandrogenism by increased A4, and DHEA along with DHEAS was significantly higher in low-BMI PCOS patients compared with high-BMI PCOS patients. Some findings observed with the BMI cutoff value of 27 kg/m(2) changed with the cutoff value of 30 kg/m(2). Conclusions: Low BMI more so than high BMI is associated with increased LH, high A4, DHEA, and DHEAS levels in PCOS patients. The BMI cutoff value of 27 kg/m(2) classified better than 30 kg/m(2) for hormonal and metabolic characteristics.
引用
收藏
页码:942 / 950
页数:9
相关论文
共 50 条
  • [1] Adrenal androgen excess in the polycystic ovary syndrome
    Azziz, R
    ENDOCRINOLOGIST, 2000, 10 (04): : 245 - 254
  • [2] Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome
    Berbrier, Danielle E.
    Leone, Cheryl A.
    Adler, Tessa E.
    Bender, Jeffrey R.
    Taylor, Hugh S.
    Stachenfeld, Nina S.
    Usselman, Charlotte W.
    JOURNAL OF APPLIED PHYSIOLOGY, 2023, 134 (04) : 868 - 878
  • [3] Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)
    Kumar, A
    Woods, KS
    Bartolucci, AA
    Azziz, R
    CLINICAL ENDOCRINOLOGY, 2005, 62 (06) : 644 - 649
  • [4] Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess
    Moran, C
    Reyna, R
    Boots, LS
    Azziz, R
    FERTILITY AND STERILITY, 2004, 81 (01) : 126 - 131
  • [5] Androgen excess: a hallmark of polycystic ovary syndrome
    Wang, Kexin
    Li, Yanhua
    Chen, Yu
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [6] Adrenal androgen participation in the polycystic ovary syndrome
    Gil Junior, Angelo Barrionuevo
    Rodrigues Rezende, Ana Paula
    do Carmo, Anselmo Verlangieri
    Duarte, Erico Isaias
    Winck Yamamoto de Medeiros, Marcia Marly
    de Medeiros, Sebastiao Freitas
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2010, 32 (11): : 541 - 548
  • [7] Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis
    Azziz, R
    Black, V
    Hines, GA
    Fox, LM
    Boots, LR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07): : 2317 - 2323
  • [8] Androgen excess is the key element in polycystic ovary syndrome
    Azziz, R
    FERTILITY AND STERILITY, 2003, 80 (02) : 252 - 254
  • [9] Polycystic ovary syndrome, androgen excess, and the impact on bone
    Zborowski, JV
    Talbott, EO
    Cauley, JA
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (01) : 135 - +
  • [10] Targets to treat androgen excess in polycystic ovary syndrome
    Luque-Ramirez, Manuel
    Francisco Escobar-Morreale, Hector
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (11) : 1545 - 1560